Immunopharmacological characterization of a new synthetic BRM : pidotimod. WorkshopDrugs under experimental and clinical research. 1993, Vol 19, issn 0378-6501, 55 p., SUPConference Proceedings

Muroctasin, a muramyl dipeptide derivative (an introductory overview)TSUBURA, E; AZUMA, I; UNE, T et al.Arzneimittel-Forschung. 1988, Vol 38, Num 7, pp 951-952, issn 0004-4172Article

Infection endoscopique dans le cancer de la vessieFUJITA, K.Yakuri to chiryo. 1987, Vol 15, Num 11, pp 543-546, issn 0386-3603Article

Situation actuelle des immunostimulants de synthèse = Synthetic immunostimulants: present statusWERNER, G. H.Annales pharmaceutiques françaises. 1994, Vol 52, Num 2, pp 61-68, issn 0003-4509Article

Endotoxin, Tochigi-ken, Japan, May 11-13,1988FRIEDMAN, HERMAN; KLEIN, T. W; NAKANO, MASAYASU et al.Advances in experimental medicine and biology. 1990, Vol 256, issn 0065-2598Conference Proceedings

Azathioprine experience in severe, generalized, recalcitrant myasthenia gravisKORNFELD, P; AMBINDER, E. P; MATTA, R et al.The Mount Sinai journal of medicine. 1985, Vol 52, Num 5, pp 347-352, issn 0027-2507Article

De la physiologie à la thérapeutique : Les immunostimulants : Situations thérapeutique en... pédiatrie = Immunostimulating drugVIC, P.Est médecine. 1997, Num 52, pp 12-13, issn 0248-9643Article

International congress on biological response modifiersJournal of immunotherapy with emphasis on tumor immunology. 1995, Vol 17, Num 2, pp 114-129, issn 1067-5582Conference Proceedings

Solution conformations of the immunomodulator muramyl peptidesSIZUN, P; PERLY, B; LEVEL, M et al.Tetrahedron (Oxford. Print). 1988, Vol 44, Num 3, pp 991-997, issn 0040-4020Article

La chimiothérapie antivirale. II: Progrès et avenir = Antiviral treatment. II: Progress and futureHURAUX, J. M; INGRAND, D.Concours médical (Paris). 1986, Vol 108, Num 21, pp 1727-1730, issn 0010-5309Article

Immunstimulierend wirkende Polysaccharide (Heteroglykane) aus höheren Pflanzen = Polysaccharides immunostimulants (Heteroglycanes) de végétaux supérieurs = Immunostimulating polysaccharides (Heteroglycans) of higher plantsWAGNER, H; PROKSCH, A; RIESS-MAURER, I et al.Arzneimittel-Forschung. 1985, Vol 35, Num 7, pp 1069-1075, issn 0004-4172Article

How food-borne peptides may give rise to their immunostimulatory activities: a look through the microbiologist's window into the immunologist's garden (hypothesis)BIZIULEVICIUS, Gediminas A.British journal of nutrition. 2004, Vol 92, Num 6, pp 1009-1012, issn 0007-1145, 4 p.Article

Advances in vaccine adjuvantsSINGH, M; O'HAGAN, D.Nature biotechnology. 1999, Vol 17, Num 11, pp 1075-1081, issn 1087-0156Article

Evidence for correlation between the intensities of adjuvant effects and NOD2 activation by monomeric, dimeric and lipophylic derivatives of N-acetylglucosaminyl-N-acetylmuramyl peptidesMESHCHERYAKOVA, Elena; MAKAROV, Evgenii; PHILPOTT, Dana et al.Vaccine. 2007, Vol 25, Num 23, pp 4515-4520, issn 0264-410X, 6 p.Article

Augmentation des résistances naturelles et médicaments homéopathiques stimulants = Immunostimulant homeopathic drugsGIAVARINI, Udo.Cahiers de biothérapie (Paris). 2005, Num 197, pp 34-37, issn 0301-1178, 4 p.Article

Strategies for enhancing the immunostimulatory effects of CpG oligodeoxynucleotidesMUTWIRI, George K; NICHANI, Anil K; BABIUK, Shawn et al.Journal of controlled release. 2004, Vol 97, Num 1, pp 1-17, issn 0168-3659, 17 p.Article

Therapeutic applications of cytokines for immunostimulation and immunosuppression : An updateCARDI, G; CIARDELLI, T. L; ERNSTOFF, M. S et al.Progress in drug research. 1996, Vol 47, pp 211-250, issn 0071-786XArticle

Biological response modifiersCLARK, J. W.Cancer chemotherapy and biological response modifiers annual. 1994, Vol 15, pp 190-212, issn 0921-4410Article

Kinetic analysis of human IL-2 activated cytotoxic cellsLEFEVER, A. V; PIASKOWSKI, V. D; CASPER, J. T et al.Immunopharmacology and immunotoxicology. 1991, Vol 13, Num 1-2, pp 147-168, issn 0892-3973Article

Structural characterization of pichilan, a β-D-glucan immunostimulant from Pichia fermentansDESBOUFS, J; RALAMBOSOA, C; ASTOIN, J et al.Chemical and pharmaceutical bulletin. 1988, Vol 36, Num 8, pp 2766-2771, issn 0009-2363Article

Cyclosporin A in the treatment of severe Behçet's uveitisBINDER, A. I; GRAHAM, E. M; SANDERS, M. D et al.British journal of rheumatology. 1987, Vol 26, Num 4, pp 285-291, issn 0263-7103Article

Stimulation de la réponse immunitaire vis-à-vis d'un antigène immobilisé, par la B-activine in vitroIVASHCHENKO, M. E; LIOZNER, A. L; BELEVSKAYA, R. G et al.Žurnal mikrobiologii, èpidemiologii i immunobiologii. 1986, Num 2, pp 84-87, issn 0372-9311Article

Lymphocyte activation by a polysaccharide fraction separated from hot water extracts of Angelica acutiloba kitagawaKUMAZAWA, Y; NAKATSURU, Y; FUJISAWA, H et al.Journal of pharmacobio-dynamics. 1985, Vol 8, Num 6, pp 417-424, issn 0386-846XArticle

Low-molecular-weight immunomodifiers produced by micro-organismsUMEZAWA, H.Biotechnology & genetic engineering reviews. 1985, Vol 3, pp 255-273, issn 0264-8725Article

Pipotimod induce morte apoptotica ed inibisce l'attivita proliferation di cellule tumorali yac-1 in vitro = Pidotimod induces apoptosis and inhibits cell proliferation of YAC-1 tumoral cells in vitroMIGLIORATI, G; NICOLLETI, I; MAGGIONI, A et al.Drugs under experimental and clinical research. 1993, Vol 19, pp 1-7, issn 0378-6501, SUPConference Paper